2001-2004 - MMS

Go to content

Main menu:


86. Hagenbuch B; Yarim M; Huber R; Moro S.; Meier Pj; Folkers G; Prediction and identification of new substrates for organic anion transporting polypeptide 1a5 using QSAR modeling. FASEB J. 18, 707-708 (2004)

85. T. De Ros, S. Moro, S. Bosi, L. Feruglio, B. Gregoretti, M. Terdoslavich, S. Passamonti, G. Decorti,G. Spalluto, M. Prato “Hemolytic effects of water-soluble fullerene derivatives.” J Med. Chem. 47, 6711-6715 (2004)

84. F. Meggio, M. A. Pagano, S. Moro, G.T TZagotto, M. Ruzzene, S. Sarno, G. Cozza, J. Bain, M.T TElliott, A. Donella Deana, A. M. Brunati. L. A. Pinna “Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.” Biochemistry 43, 12931-12936 (2004)

83. A. Guiotto, M. Canevari, M. Pozzobon, S. Moro, P.Orsolinib, M. Veronese “Anchimeric assistance e.ect on regioselective hydrolysis of branched PEGS: a mechanistic investigatigation”. Bioorg. Med.Chem. 19, 5031-5037 (2004)

82. Colotta V, Catarzi D, Varano F, Calabri FR, Lenzi O, Filacchioni G, Martini C, Trincavelli L, Deflorian F, Moro S. “1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.” J Med. Chem. 47, 3580-3590 (2004)

81. S. Moro, G.L. Beretta, D. Dal Ben, J. Nitiss, M. Palumbo, G. Caprinico “Interaction model for anthracycline activity against DNA topoisomerase II.” Biochemistry 43, 7503-7513 (2004)

80. E. Boseggia, S. Moro, M. Gatos, L. Lucatello, F. Mancin, M. Palumbo, C. Sissi, P. Tecilla, U. Tonellato, G. Zagotto “Toward efficient Zn(II)-based artificial nucleases.” J. Am. Chem. Soc. 126, 4543-4549 (2004)

79. O. Schiavon, G. Pasut, S. Moro, P. Orsoline, A. Guitto, F.M. Veronese “PEG-ARAC conjugates for controllaled release. Eur. J. Med. Chem. 39, 123-133 (2004)

78. C. Sissi, E. Leo, S. Moro, G. Capranico, A. Mancia, E. Menta, A.P. Krapcho, M. Palumbo “Antitumor Aza-anthrapyrazoles: biophysical and biochemical studies on 8- and 9-aza regioisomers.” Biochem. Pharmacol. 67, 631-42 (2004)

77. D. Vedaldi, A. Dolmella, S. Moro, G. Miolo, G. Viola, S. Caffieri, F. Dall’Acqua “1-Thioangelicin: crystal structure, computer-aided studies and photobiological activity.” Farmaco 59, 125-132 (2004)

76. S. Moro, F. Deflorian, K.A. Jacobson, G.Spalluto, G. Pastorin, B. Cacciari “Demystifying the Three Dimensional Structure of G Protein-Coupled Receptors with the Aid of Molecular Modeling.” J. Chem. Soc. Chemm. Comm. 24, 2949-2956 (2003)

75. P. Pengo, L. Pasquato, S. Moro, A. Brigo, F. Fogolari, Q.B. Broxterman, B. Kaptein,.P. Scrimin “Quantitative Correlation of Solvent Polarity with the alfa-/310-Helix Equilibrium: A Heptapeptide Behaves as a Solvent-Driven Molecular Spring.” Angew. Chem. Int. Ed. 42, 3388–3392 (2003)

74. G. Pastorin,T. Da Ros, G. Spalluto, B. Cacciari, S. Moro, F. Deflorian, K. Varani, S. Gessi, P.A. Borea “Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists: influence of the N5 substituent on the affinity at the human AB3B and AB2BB adenosine receptor subtypes.” J Med. Chem. 46, 4287-4296 (2003)

73. M. Bonchio, O. Bortolini, G. Licini, S. Moro, W. A. Nugent “On The Mechanism of the Oxygen Transfer to Sulfoxides by Ti(IV)/Trialkanolamine/Peroxo Complexes. Evidence for a Metal Template Process.” Eur. J. Org. Chem. ,507-511(2003)

72. E. De Moliner, S. Moro, S. Sarno, G. Zagotto, G. Zanotti, L.A. Pinna, R.Battistutta “Inhibition of protein kinase CK2 by anthraquinone related compounds: A structural insight.” J. Biol. Chem. 278, 1831-1836 (2003)

71. O. Bortolini, M. Carraro, V. Conte, S. Moro, “Vanadium-Bromoperoxidase-Mimicking Systems: Direct Evidence of a Hypobromite-like Vanadium Intermediate.” Eur. J. Inorg. Chem. 12, (2002)

70. M. Palumbo, B. Gatto, S. Moro, C. Sissi, G. Zagotto “Sequenze-specific interactions of drugs interfering with the topoisomerase-DNA cleavage complex.” Biochim. Biophys. Acta 1587, 145-154 (2002)

69. S. Moro, K. A. Jacobson “Molecular modeling as tool to investigate molecular recognition in P2Y receptors.” Curr. Pharm. Des. 8, 99-110 (2002)
68. G. Viola, F. Dall’Acqua, N. Gabellini, S. Moro, D. Vedaldi, H. Ihmels “Indolo [2,3-b ]-quinolizinium bromide: An efficient intercalator with DNA-Photodamaging Properties” Chem. BioChem. 3, 101-109 (2002)

67. A. Maconi, G. Pastorin, T. Da Ros, G. Spalluto Z.-g. Gao, K.A. Jacobson,P PP.G. Baraldi, B. Cacciari, K. Varani,  S. Moro, P.A. Borea “Synthesis, Biological Properties and Molecular Modeling Investigation of the First Potent, Selective and Water Soluble Human AB3B Adenosine Receptor Antagonist” J Med. Chem. 45, (2002)

66. P.G. Baraldi, S. Moro, R. Makaeva, M.G. Pavani, M.delC. Nunez, G. Spalluto, G. Falzoni, F. Di Virgilio, R. Romagnoli “Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor containing a tyrosine moiety.” Arzneimittelforschung 52, 273-285 (2002)

65. K.A. Jacobson, S. Moro, J.A. Manthey, P. West, X.-d. Ji “Interaction of flavonoids and other phytochemicals with adenosine receptors. In Flavonoids in Cell Function.” Buslig, B., Manthey, J., eds., 2002, Kluwer Acedemic/Plenum, New York, pp. 163-171

64. S. Sarno, S. Moro, F. Meggio, G. Zagotto, D. Dal Ben, L. A. Pinna “Toward the rational design of protein kinase CK2 inhibitors.” Pharmacol. Ther. 93, 1-10 (2002)

63. P.G. Baraldi, B. Cacciari, S. Moro, R. Romagnoli, G. Spalluto, G. Pastorin, T. Da Ros, K.N. Klotz, E. Leung, K. Varani, S. Gessi, S. Merighi, P.A. Borea “Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as human AB3B adenosine receptor antagonists.” J Med. Chem. 45, 770-780(2002)

62. T. Da Ros, M. Bergamin, G. Spalluto, B. Baiti, S. Moro,P P M. Prato, A. Boutorine ”Synthesis, molecular modeling and biological evaluation of fullerene-trimethoxyindole-oligonucleotide conjugates: a possible probe for studing photochemical reactions in DNA triple helices.” Eur. J. Org. Chem. 3, 405-413 (2002)

61. M. Palumbo, S. Moro, B. Gatto, C. Sissi, G. Zagotto “Quantitation of camptothecin and related compounds.” J. Chromatogr. B Biomed. Sci. Appl. 64, 121-140 (2001)

60. G. Zagotto, S. Moro, B. Gatto, C. Sissi, M. Palumbo “Anthracyclines: recent developments in their separation and quantitation.” J. Chromatogr. B Biomed. Sci. Appl. 64, 161-171 (2001)

59. S. Richter, L. Panella, S. Moro, G. Capranico, M. Palumbo, B. Gatto “Clerocidin alkylates DNA: implications for irreversible topoisomerase II-mediated DNA damage.” Nucleic Acid Res. 29, 4224-30 (2001)

58. M. Bonchio, O. Bortolini, V. Conte S. Moro “Characterization and Reactivity of Triperoxo Vanadium Complexes In Protic Solvents.” Eur. J. Inorg. Chem. 11, 2719-2738 (2001)

57. F. Meggio, S. Moro, A. D. Deana, D. Dal Ben, S. Sarno, G. Fagotto, L. A. Pinna “Molecular Features of selective polyphenolic inhibitors of Protein kinase CK2.” Cell. Biol. Mol. Lett. 6, 503-506 (2001)

56. K. A. Jacobson, R.G. Ravi, S. Moro, E. Nandanan, H. S. Kim, Y. C. Kim, K. Lee, Barak, D., Marquez, V.E., and Ji, X.D. “Ribose modified nucleosides and nucleotides as ligands for purine receptors.” Nucleosides Nucleotides 20, 333-341 (2001)

55. K. A.Jacobson, S. Moro, P. West, X.-d. Ji “Interaction of flavonoids and other phytochemical with adenosine receptors. in Flavinoids in Cell Function. Buslig B, and Manthey J eds., 2001, Kluwer Acedemic/Plenum, New York.

54. P. G. Baraldi, B. Cacciari, S. Moro, R. Romagnoli, X.D. Ji, K. A. Jacobson, G. Spalluto “Fluorosulfonyl- and bis-(alfa-chloroethyl)amino- phenylamino functionalized pyrazolo[4,3e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as irreversible antagonists at the human A3 adenosine receptor. J Med. Chem. 44, 2735-2742 (2001)

53. C. Sissi, S. Moro, S. Richter, B. Gatto, EP. PMenta, S. Spinelli, A.P. Krapcho, F. Zunino, M. Palumbo “DNA-interactive aza-anthrapyrazoles: biophysical and biochemical studies relevant to the mechanism of action”. Mol. Pharmacol. 59, 96-103 (2001)

52. K. A. Jacobson, S. Moro, C. Hoffmann, Y.-C. Kim, H. S. Kim, R. G. Ravi, T. K. Harden, J. L. Boyer “Structurally related nucleotides as selective agonists and antagonists at P2YB1B receptors” Farmaco 56, 71-75 (2001)

Back to content | Back to main menu